Pharmacological Aspects of Ligand-gated Ion Channels as Targets of Natural and Synthetic Agents

170.1K

views

103

authors

18

articles

Pharmacological Aspects of Ligand-gated Ion Channels as Targets of Natural and Synthetic Agents

170.1K

views

103

authors

18

articles

Editorial

08 April 2022

Editorial: Pharmacological Aspects of Ligand-Gated Ion Channels as Targets of Natural and Synthetic Agents

César Mattei

,

Hélène Tricoire-Leignel

,

Christian Legros

,

Richard J. Lewis

and

Jordi Molgó

1,623 views

1 citations

Editors

5

The University of Queensland

Helene TRICOIRE-LEIGNEL

Université d'Angers

Jordi MOLGO

Centre National de la Recherche Scientifique (CNRS)

Impact

About

In the central and peripheral nervous system, as well as in their effectors (heart, muscles, vessels), neurotransmitters target postsynaptic receptors with high affinity and specificity, resulting in the transmission of excitatory or inhibitory information.

When these receptors are coupled to an ion channel, they are called ligand-gated ion channels (LGICs). These receptors have been studied for decades because their functions are crucial in cellular communication and they are involved in many significant neuropathologies, including genetic channelopathies that affect the nervous system.

In addition, these receptors are the target of chemicals synthesized for therapeutic and phytosanitary purposes, but also of natural molecules derived from animal or plant toxins. All of them modulate the receptors’ activity and restore - or disrupt - their physiological functions.

Moreover, increasingly important works show that these LGICs are also the target of synthetic pesticide agents, which are originally supposed to specifically act on invertebrate targets but, however, have shown to have the capacity to disrupt non-target system receptors.

This Research Topic is open to authors working on the pharmacology of ionotropic receptors (namely GABA, acetylcholine, glutamate, ATP, glycine, serotonin) and the modulation of their activity by insecticide molecules, natural toxins, anxiolytics, and others, acting as agonists, antagonists or allosteric modulators.

The purpose of this Research Topic is to gather recent advances on LGICs at multiple scales (in silico to in vivo) using different approaches (electrophysiology, cell biology, biochemistry, molecular modeling, genetic animal models etc.) to highlight their function and dysfunction in the context of physiological processes, as well as associated pathologies or acute and chronic intoxications. Original Research articles, Review articles and as short communications are welcome.

Download ebook

PDF

EPUB

Share

Editors

The University of Queensland

Helene TRICOIRE-LEIGNEL

Université d'Angers

Jordi MOLGO

Centre National de la Recherche Scientifique (CNRS)

Impact

170,062 Total views

143,345 Article views

23,876 Article downloads

2,841 Topic views

Published In

Frontiers in Neuroscience

Neuropharmacology

Frontiers in Pharmacology

Neuropharmacology

Frontiers in Molecular Neuroscience

Molecular Neuroscience Archive, Brain Disease Mechanisms, Molecular Signalling and Pathways, Methods and Model Organisms, Pain Mechanisms and Modulators, Neuroplasticity and Development

Frontiers in Psychiatry

Neuropharmacology

Frontiers in Neurology

Neuropharmacology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic